GlobeNewswire by notified

Ageas announces the payment of final instalments in the Fortis settlement

Share

Ageas announces the payment of final instalments in the Fortis settlement

Ageas announces today that it has decided, in agreement with the claimant organisations, to close the Fortis settlement enabling the claims administrator to proceedto the payment of final instalments.

Initially final calculations for all claimants and payment of final instalments would only be made after the very last dispute has been resolved. However, as only a very limited number of claims are still pending before Computershare (the independent claims administrator) or the Dispute Committee, Ageas did not want to let this limited number of unresolved claims keep some 279,000 other claimants waiting any longer.
Therefore, Ageas decided to bear the residual risk of these unresolved claims on top of the EUR 1.3 billion budget provided in the Settlement Agreement. This allows the claims administrator to proceed to the payment of the final instalments and thereby close the Fortis settlement for almost all claimants.

As significantly more claims were filed than expected, some components of a claimant’s Provisional Claim Amount will be subject to dilution.

In determining the final payment percentages mentioned below, the unresolved claims are deemed to be rejected, which maximizes the pay-out amounts for all other claimants within the foreseen budget of EUR 1.3 billion.
The resulting payment percentages are applied to the corresponding compensation component of a claimant’s Provisional Claim Amount to calculate a claimant’s Final Claim Amount:

  • Buyer Shares:                                        100%
  • Holder Shares:                                       77.48%
  • Compensation Add-On:                          61.62%
  • Cost Addition for Active Claimants:        120%

Given that fewer claims for Buyer Shares were filed than expected, buyers of Fortis Shares will receive 100% of the Buyer Share component of their Provisional Claim Amount.

Even after adding the excess funds of EUR 198.3 million transferred from the Buyer Shares bucket to the Holder Shares bucket, the pay-out percentage for Holder Shares is diluted to 77.48%.

For Active Claimants, the Cost Addition component will be increased up to the maximum of 120% provided for in the approved distribution plan.

The Compensation Add-On is most affected by the high number of claims filed, yielding a pay-out percentage of 61.62%.

A claimant’s final instalment will be the positive difference between the claimant’s Final Claim Amount and the instalment(s) already received. For non-Active Claimants whose compensation is primarily or exclusively composed of Compensation Add-On and/or Holder Shares the final instalment may be limited or zero. “Early filers” benefitted from a guaranteed pay-out of 70% of their Provisional Claim Amount and they may keep any overpayment if their Final Claim Amount is lower than the 70% of their Provisional Claim Amount they received as a first instalment.

In the days following 23 June 2022 each claimant with an accepted claim will receive a letter with the claimant’s Final Claim Amount and the amount of the final instalment, if any, by email or by regular post. The final payment will normally follow on or about 25 August 2022.

Ageas kindly asks claimants to be patient and to refrain from calling or emailing the call centre to get info about their specific, individual claim before they have received their letter. Before such time the call centre will not yet have the details of their Final Claim Amount. The call centre can be reached by telephone Monday through Friday from 9:00 until 18:00 CET. Ageas advises claimants to first consult the FORsettlement website (www.forsettlement.com) if they have any questions about this communication.

“I want to express my gratitude to the many claimants who have been waiting so patiently for closure and thank all organisations and persons involved in getting us to where we are today. With this decision Ageas again takes a major step, allowing the Group to fully focus on its business and to continue with the execution of its strategic plan Impact24.”
Hans De Cuyper, CEO Ageas

Ageas is a listed international insurance Group with a heritage spanning almost 200 years. It offers Retail and Business customers Life and Non-Life insurance products designed to suit their specific needs, today and tomorrow. As one of Europe's larger insurance companies, Ageas concentrates its activities in Europe and Asia, which together make up the major part of the global insurance market. It operates successful insurance businesses in Belgium, the UK, France, Portugal, Turkey, China, Malaysia, India, Thailand, Vietnam, Laos, Cambodia, Singapore, and the Philippines through a combination of wholly owned subsidiaries and long term partnerships with strong financial institutions and key distributors. Ageas ranks among the market leaders in the countries in which it operates. It represents a staff force of about 40,000 people and reported annual inflows close to EUR 40 billion in 2021 (all figures at 100%).

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

U.S. Government Orders Additional Monkeypox Vaccines from Bavarian Nordic1.7.2022 16:00:10 CEST | Press release

Bavarian Nordic to supply an additional 2.5 million doses of JYNNEOS® vaccineDoses will be manufactured using existing bulk vaccine from previous orders from BARDADeliveries starting in the fourth quarter of 2022 with the majority to be delivered in 2023 COPENHAGEN, Denmark, July 1, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, has ordered an additional 2.5 million doses of liquid-frozen JYNNEOS®, a non-replicating smallpox vaccine and the only FDA-approved vaccine against monkeypox. Deliveries under this contract will start in the fourth quarter of 2022 and continue through early 2023. This order comes a few weeks after an order from BARDA for the delivery of 500,000 doses of the vaccine in 2022 in response to the current monkeypox outbreak. With a previous order from BARD

Den amerikanske regering bestiller yderligere vacciner mod abekopper fra Bavarian Nordic1.7.2022 16:00:10 CEST | pressemeddelelse

Bavarian Nordic skal levere yderligere 2,5 mio. doser JYNNEOS® vaccineRåvaccine, produceret under tidligere kontrakter med BARDA, vil blive anvendt til færdigproduktion af doserneLeverancerne vil starte i fjerde kvartal 2022 og fortsætte ind i 2023, hvor hovedparten af doserne vil blive leveret KØBENHAVN, Danmark, 1. juli 2022 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at Biomedical Advanced Research and Development Authority (BARDA), en del af Office of the Assistant Secretary for Preparedness and Response ved U.S. Department of Health and Human Services, har bestilt yderligere 2,5 mio. doser af den flydende-frosne udgave af JYNNEOS®, en ikke-replikerende koppevaccine, og den eneste FDA-godkendte vaccine mod abekopper. Leverancerne vil starte i fjerde kvartal 2022 og fortsætte ind i begyndelsen af 2023. Denne ordre er afgivet få uger efter en anden ordre fra BARDA på levering af 500.000 doser af vaccinen i 2022 til brug i forbindelse med det aktuelle udbrud af abekopper. Med en

Incap Corporation: INCAP GROUP’S HALF-YEAR FINANCIAL REPORT FOR JANUARY–JUNE 2022 AND WEBCAST 28 JULY 20221.7.2022 14:30:00 CEST | Press release

Incap Corporation Press release 1 July 2022 at 3:30 p.m. EEST The corrected release includes the time of the webcast. Incap Group’s half-year financial report for January–June 2022 will be published on Thursday, 28 July 2022 at approximately 09:00 a.m. Finnish time. At that time, reporting materials in Finnish and English will be available on the company's website at https://incapcorp.com/reports-and-presentations/. Webcast The company will hold a webcast on Thursday, 28 July 2022 at 2:00 p.m. EEST. The result will be presented by Otto Pukk, CEO, and Antti Pynnönen, CFO, Incap Corporation. In addition to the result, Incap's UK operations will be presented at the event, and Jamie Maughan, Director of Operations UK will participate in the event. The live webcast can be followed at https://incap.videosync.fi/2022-07-28-half-year-report. During the webcast, the public can ask questions in the chat room at the address mentioned above. The recording of the broadcast will be available on the

Incap Corporation: INCAP GROUP’S HALF-YEAR FINANCIAL REPORT FOR JANUARY–JUNE 2022 AND WEBCAST 28 JULY 20221.7.2022 14:00:00 CEST | Press release

Incap Corporation Press release 1 July 2022 at 3:00 p.m. EEST Incap Group’s half-year financial report for January–June 2022 will be published on Thursday, 28 July 2022 at approximately 09:00 a.m. Finnish time. At that time, reporting materials in Finnish and English will be available on the company's website at https://incapcorp.com/reports-and-presentations/. Webcast The company will hold a webcast on Thursday, 28 July 2022 at xx:00 p.m. EEST. The result will be presented by Otto Pukk, CEO, and Antti Pynnönen, CFO, Incap Corporation. In addition to the result, Incap's UK operations will be presented at the event, and Jamie Maughan, Director of Operations UK will participate in the event. The live webcast can be followed at https://incap.videosync.fi/2022-07-28-half-year-report. During the webcast, the public can ask questions in the chat room at the address mentioned above. The recording of the broadcast will be available on the company's website at https://incapcorp.com/reports-and-

FLSmidth to deliver process technology for greenfield cement plant in Asia1.7.2022 13:43:18 CEST | Press release

FLSmidth has won a contract to supply a series of state-of-art equipment for a greenfield cement plant in Asia. The order is valued at more than DKK 400 million and has been booked in Q2 2022. The equipment will be supplied during 2023. The contract includes among other technologies; the FLSmidth OKTM Raw Mill, OKTM Cement Mill and Low NOx ILC preheater, which are flagships in FLSmidth’s MissionZero programme for Cement. "This project showcases FLSmidth’s ability to deliver energy efficient technologies across the full cement flowsheet and thereby supporting our customers in both increasing capacity and their sustainability efforts,” says Carsten Riisberg Lund, Cement Industry President, FLSmidth. Contacts: Investor Relations Jannick Lindegaard Denholt, +45 21 69 66 57, jli@flsmidth.com Therese Möllevinge, +45 41 37 16 38, tmo@flsmidth.com Mikkel Johansen, +45 23 30 29 50, mjoh@flsmidth.com Media Relations Rasmus Windfeld, +45 40 44 60 60, rwin@flsmidth.com About FLSmidth FLSmidth prov